In May 2012, the then Immigration Minister Damian Green announced a new scheme for the screening of immigrants to the UK from countries with a high incidence of tuberculosis before they are granted a visa for entry into the UK. The new measures were brought in as figures for 2011 showed over 9000 new cases of active tuberculosis in the UK, with non-UK born people accounting for three quarters of them.
If the government considers pre-entry screening to be worthwhile for tuberculosis, why not for hepatitis B virus (HBV) infection, the frequency of which has risen substantially in the UK as a consequence of immigration? The numbers involved are comparable with an estimated 6500 new cases of chronic HBV infection entering the UK each year. Over 90 000 immigrants have come from countries with high HBV prevalence (>8% HBsAg positivity, whereas prevalence in the UK is 0·25%).1 In 2007, 193 888 of the estimated total of 326 338 chronically infected people in the UK were born in other countries, double that in 2007 and today's figure is likely to be significantly higher.2 Eight of the ten top non-EU countries from which immigrants come are countries of high or intermediate (2—8%) HBV seroprevalence according to the UK Council for International Student Affairs. The CUSHI-B study—a survey of chronic HBV infection comprising patients in active follow—up attending 15 UK liver centres—showed that 81% of the 1 147 patients registered were born outside the UK.3 Individuals from Pakistan accounted for the highest number (15%) with persons born in Hong Kong and in China only a short way behind (11% and 12%, respectively). The Liver Unit in Birmingham, a city with a large immigrant population, has seen an almost five-fold increase in the number of new HBV referrals between 2001 and 2010.4 Resurgence of supra infection with the delta virus in HBsAg positive individuals is another important public health problem (especially in areas with substantial numbers of immigrants from Africa and Eastern Europe)5 because it creates a pool of infection resistant to antiviral therapy, and one associated with more rapid disease progression to cirrhosis.
read more here ..
http://www.thelancet.com/journals/la...lltext?rss=yes